Answer
Breastfeeding should be discontinued throughout vorasidenib treatment and for at least 2 months after the last dose.
Sources for this answer
- Voranigo 10 mg film-coated tabletServier Laboratories Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked